Thus, we presumed that SNORD1A co‐expressed genes might produce effects in DLBCL through MYC and RPL10A mutations, of which RPL10A mutations might interact with p53, providing novel insights into the molecular mechanism of DLBCL. The gene discussed is SNORD1A; the disease is diffuse large B-cell lymphoma.